Lymphedema refers to swelling that typically occurs in one or more limbs as a result of a blockage in the lymphatic system. It most commonly occurs in an arm or leg after breast cancer treatment or as a result of damage to the lymphatic system. Treatment options include compression garments, compression bandaging, manual lymph drainage, and complex decongestive therapy.
The global lymphedema treatment market is estimated to be valued at US$ 2.29 Bn in 2023 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The lymphedema treatment market is driven by rising prevalence of lymphatic disorders such as lymphedema due to increasing incidence of obesity and cancer. According to the National Cancer Institute, lymphedema often occurs in 10-30% of breast cancer patients and 20% of melanoma patients treated conservatively. Rising awareness regarding early detection and management of lymphedema is also expected to fuel the market growth over the forecast period. The key driver is rising prevalence of lymphatic disorders which is increasing due to growing obesity rates and increasing cancer cases globally. However, high cost of advanced compression therapy products and lack of reimbursement policies in developing nations are some factors that may hinder market growth.
SWOT Analysis
Strength: Lymphedema treatment market has various treatment options available such as compression therapy, laser therapy, medical devices treatment. Compression therapy is commonly used as it effectively treats swelling by applying pressure on affected area and stimulates lymph flow, reducing edema.
Weakness: Lymphedema treatment has limited prevention and cure options available which leads to high treatment costs. It requires lifelong management once developed. Accurate diagnosis is challenging for doctors which delays proper treatment.
Opportunity: Rise in cancer and chronic illnesses increasing prevalence of lymphedema globally presents lucrative scope. Advent of new modalities like laser therapy and medical devices treatment provides growth path. Growing awareness regarding lymphedema management enhances outlook.
Threats: Presence of alternative treatment therapies and lack of comprehensive research on lymphedema hampers market growth. Unfavourable reimbursement policies especially in developing regions pose challenges.
Key Takeaways
The global lymphedema treatment market is expected to witness high growth over the forecast period. Global Lymphedema Treatment Market Size is estimated to reach US$ 2.29 Billion in 2024, expanding at a robust CAGR of 21% between 2024-2031.
Regional analysis: North America currently dominates global market share owing to advanced healthcare system and supporting reimbursement policies promoting treatment uptake. Asia Pacific presents immense opportunities ascribed to increasing healthcare expenditure, expanding patient pool of chronic diseases and rising medical tourism.
Key players: Key players operating in the lymphedema treatment market are Walmart Inc., Under Armour, Inc., Givex Corporation, American Express, Target Brands, Inc., Best Buy, Starbucks Coffee Company, PayPal Holdings, Inc., Apple Inc., Sephora USA, Inc., Gyft, Inc., Walgreen Co., TransGate Solutions, AMILON S.R.L., Jigsaw Business Solutions, Diggecard, Pine Labs Private Limited, Alltimeprint.com, Plastek Card Solutions, Inc., Card USA, Inc., Duracard, Blackhawk Network, Tango Card. Inc, Stockpile, Inc., and Huuray A/S among others.
Get More Insights on this Topic- https://www.trendingwebwire.com/lymphedema-treatment-market-sizeshare-and-demand/
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) Forecast to 2027Market ScopeMarket Research Future (MRFR) studied the global lymphedema treatment market 2021 for the analysis tenure till 2025.
The rise in research activities for the development of new drugs to treat lymphedema drawing funds from top-notch investors for the commercialization of novel drug formulations.
The existing treatment of lymphedema i.e., surgery and radiation therapy, are not effective, as reappearance of lymphedema is often reported after months or years.
Thus, the inclination towards the need for effective drug for treating lymphedema can add impetus to the market growth.
Favorable reimbursement policies, along with the support of government for affording treatment, are additional causes that can benefit the lymphedema treatment market.
On the contrary, limited availability of treatment options for lymphedema can hinder the market rise.
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2025Global Market – OverviewThe increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.The strong clinical pipeline is likely to boost the market growth.
Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin.
Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema.
The market potential of the drug is estimated to be around USD 650 MillionKey Players3A Health Care (Italy)Bio Compression Systems, Inc. (US)Devon Medical Products (US)HERANTIS PHARMA PLC (Finland)Lohmann & Rauscher (Germany)Mego Afek Ltd (US)SIGVARIS (Switzerland)Tactile Systems Technology Inc. (US)Wright Therapy Products (BSN Medical) (Germany) Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8440Market InfluencerIncreased research & development in the market is estimated to influence the commercialization in the market.
The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.Market DriversIncreasing cancer casesLymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.It is reported that a majority of the lymphedema cases affect cancer patients.
However, in certain cases, lymphedema is reported after months or years of cancer treatment.
